Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Genitourinary 1

Conditions

Sexual Dysfunction, Physiological 1Prostatic Neoplasms 1

Interventions

Psychiatric Rehabilitation 6Surveys and Questionnaires 5Counseling 4Therapeutics 3Radiotherapy 3Sildenafil Citrate 2High-Intensity Focused Ultrasound Ablation 2Exercise 2trametinib 1sotorasib 1selpercatinib 1pembrolizumab 1osimertinib 1methyl N-acetylsibirosaminide 1methyl 3-mercaptopropionimidate 1lorlatinib 1dabrafenib 1cemiplimab 1brigatinib 1bicalutamide 1alectinib 1Vitamin E 1Vitamin D 1Uterine Myomectomy 1Testosterone Propionate 1Testosterone 1Tadalafil 1Surgical Procedures, Operative 1Sexual Health 1Sex Education 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sexual Dysfunction, Physiological × Tadalafil × Other × Clear all
NCT00931528 2018-02-14

Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy

Radiation Therapy Oncology Group

Phase 3 Completed
242 enrolled 13 charts
GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡